Nov 1, 2018 · 26 min
Business
The Readout Loud
STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
- 416 episodes
- Updated Thursday
Episodes416
Oct 25, 2018 · 21 minEpisode 34: Pharma at the ballot box, the latest Alzheimer's argument, and a rare disease dilemma
Oct 18, 2018 · 24 minEpisode 33: Drug prices on TV, immortal blockbusters, and genetic privacy
Oct 11, 2018 · 22 minEpisode 32: Fake friends at the FDA, cancer counter-narratives, and biotech's bear turn
Oct 4, 2018 · 23 minEpisode 31: Nobel snubs, millenial founders, and a new kind of lightning round
Sep 27, 2018 · 25 minEpisode 30: A fish oil epiphany, VC monopolies and ketamine clinics
Sep 20, 2018 · 24 minEpisode 29: A Hong Kong heat-check, a $20 million wrist slap, and pharma's (other) diversity problem
Sep 13, 2018 · 22 minEpisode 28: Founders' funds, doctors' disclosures, and the subtle art of beeping
Sep 6, 2018 · 26 minEpisode 27: Live from Boston!
Aug 30, 2018 · 17 minEpisode 26: FDA shows its teeth, biotech fish oil might be pointless, & treating McCain's cancer
Aug 23, 2018 · 21 minEpisode 25: A genome-editing first, Trump on Wall Street, and biotech red flags
Aug 16, 2018 · 23 minEpisode 24: A lesson in startup jargon, pharma's bare Alzheimer's cupboard, and the cost of CAR-T
Aug 9, 2018 · 21 minEpisode 23: Congressional insider trading, PETA and fake meat, & doctors vs. fund managers
Aug 2, 2018 · 23 minEpisode 22: Biotech's battle for talent, Sanofi's second act, and climbing Mt. Everest
Jul 26, 2018 · 24 minEpisode 21 - A debatable Alzheimer's breakthrough, Gilead's golden age, and "robust" data
Jul 19, 2018 · 25 minEpisode 20 - CRISPR freakouts, drug prices meet elections, and a busy earnings season
Jul 12, 2018 · 24 minEpisode 19: Trump's telephonic prowess, Biogen's mysterious future, & the rise of 'hypelines'
Jul 5, 2018 · 19 minEpisode 18: Biotech's six-month review, how to become a day trader and soul-searching analysts
Jun 28, 2018 · 23 minEpisode 17: A friendly FDA, biosimilar awkwardness and how to sell drugs in China
Jun 21, 2018 · 25 minEpisode 16: Sarepta's big week, Theranos' legal woes and parsing AI hype